US Food and Drug Administration. Pulmonary-Allergy Drugs Advisory Committee Meeting September 10, 2013 - Combination therapy - Document - PDFSEARCH.IO

First Page	Meta Content
	US Food and Drug Administration. Pulmonary-Allergy Drugs Advisory Committee Meeting September 10, 2013 Add to Reading List Open Document File Size: 719,91 KB Share Result on Facebook Company Glaxosmithkline plc / / Event FDA Phase / / IndustryTerm combination product / / MedicalCondition emphysema / chronic obstructive pulmonary disease / COPD / chronic bronchitis / / Organization Pulmonary / Allergy / and Rheumatology Products Office / New Drugs Center for Drug Evaluation / Division of Pulmonary / US Food and Drug Administration Pulmonary-Allergy Drugs Advisory Committee / US Food and Drug Administration / / Person Susan Limb / LAMA LABA / LAMA LAMA LABA / / Position Clinical Team Leader / / Product Fluticasone propionate / Duoneb / albuterol / Advair Diskus / Symbicort / Combivent / Discuss / / SocialTag Combination drugs GlaxoSmithKline Chronic lower respiratory diseases Alcohols Fluticasone/salmeterol Chronic obstructive pulmonary disease Formoterol Budesonide/formoterol Salmeterol Pulmonology

US Food and Drug Administration. Pulmonary-Allergy Drugs Advisory Committee Meeting September 10, 2013Add to Reading List